Self-protecting bactericidal titanium alloy surface formed by covalent bonding of daptomycin bisphosphonates.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 2987735)

Published in Bioconjug Chem on October 15, 2010

Authors

Chang-Po Chen1, Eric Wickstrom

Author Affiliations

1: Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, United States.

Articles cited by this

Prosthetic-joint infections. N Engl J Med (2004) 12.71

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science (2003) 7.73

Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature (2008) 4.87

Antibacterial peptides: basic facts and emerging concepts. J Intern Med (2003) 4.44

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother (2005) 3.34

Glycopeptide and lipoglycopeptide antibiotics. Chem Rev (2005) 3.01

Designing surfaces that kill bacteria on contact. Proc Natl Acad Sci U S A (2001) 2.93

Infection after total hip arthroplasty. Past, present, and future. J Bone Joint Surg Am (1995) 2.83

Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect Dis (2005) 2.37

Surface-bonded antimicrobial activity of an organosilicon quaternary ammonium chloride. Appl Microbiol (1972) 1.94

Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials (2005) 1.72

Factors in pin tract infections. Orthopedics (1991) 1.52

Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res (2007) 1.35

'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. Chem Soc Rev (2006) 1.29

The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials (2008) 1.21

Comparative properties of siloxane vs phosphonate monolayers on a key titanium alloy. Langmuir (2005) 1.19

Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus. Chem Biol (2005) 1.16

Immobilization of the cell-adhesive peptide Arg-Gly-Asp-Cys (RGDC) on titanium surfaces by covalent chemical attachment. J Mater Sci Mater Med (1997) 1.14

Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Relat Res (2007) 1.14

Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg Med Chem Lett (2007) 0.99

Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug Chem (2006) 0.96

Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin. Bioorg Med Chem Lett (2003) 0.96

Titanium implant materials with improved biocompatibility through coating with phosphonate-anchored cyclic RGD peptides. Chembiochem (2005) 0.94

Chitin/PLGA blend microspheres as a biodegradable drug delivery system: a new delivery system for protein. Biomaterials (2003) 0.93

Antibacterial surfaces on expanded polytetrafluoroethylene; penicillin attachment. Biomacromolecules (2007) 0.90

Microencapsulation of gentamicin in biodegradable PLA and/or PLA/PEG copolymer. J Microencapsul (2001) 0.90

Use of selected medical device implants in the United States, 1988. Adv Data (1991) 0.83

Attachment of ampicillin to expanded poly(tetrafluoroethylene): surface reactions leading to inhibition of microbial growth. Biomacromolecules (2008) 0.82

The effectiveness of antibiotic activity of penicillin attached to expanded poly(tetrafluoroethylene) (ePTFE) surfaces: a quantitative assessment. Biomacromolecules (2007) 0.81

Array synthesis of novel lipodepsipeptide. Bioorg Med Chem Lett (2003) 0.80

Ligand-modified aminobisphosphonate for linking proteins to hydroxyapatite and bone surface. Bioconjug Chem (2007) 0.79

Benzylprotected aromatic phosphonic acids for anchoring peptides on titanium. Bioorg Med Chem Lett (2005) 0.77

Bactericidal activity of extended 9-glycyl-amido-minocyclines. Bioorg Med Chem Lett (2007) 0.77

Articles by these authors

Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res (2007) 1.35

Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J Biol Chem (2004) 1.29

Frank Stinchfield Award. Titanium surface with biologic activity against infection. Clin Orthop Relat Res (2004) 1.25

The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials (2008) 1.21

Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus. Chem Biol (2005) 1.16

Targeted gene knockdown in zebrafish using negatively charged peptide nucleic acid mimics. Dev Dyn (2003) 1.13

Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1. Bioconjug Chem (2007) 1.07

PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog. J Nucl Med (2004) 1.04

Characterization of mutations and loss of heterozygosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction. BMC Biotechnol (2003) 1.02

External imaging of CCND1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras. Ann N Y Acad Sci (2005) 0.99

Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg Med Chem Lett (2007) 0.99

Nanotube-antibody biosensor arrays for the detection of circulating breast cancer cells. Nanotechnology (2008) 0.99

Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acids. Nucleic Acids Res (2005) 0.97

PET imaging of VPAC1 expression in experimental and spontaneous prostate cancer. J Nucl Med (2007) 0.95

External imaging of CCND1 cancer gene activity in experimental human breast cancer xenografts with 99mTc-peptide-peptide nucleic acid-peptide chimeras. J Nucl Med (2004) 0.94

Noninvasive molecular imaging of MYC mRNA expression in human breast cancer xenografts with a [99mTc]peptide-peptide nucleic acid-peptide chimera. Bioconjug Chem (2005) 0.93

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation. Regul Pept (2007) 0.93

EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities. Cancer Biol Ther (2006) 0.93

PET imaging of CCND1 mRNA in human MCF7 estrogen receptor positive breast cancer xenografts with oncogene-specific [64Cu]chelator-peptide nucleic acid-IGF1 analog radiohybridization probes. J Nucl Med (2007) 0.88

Molecular determinants of epidermal growth factor binding: a molecular dynamics study. PLoS One (2013) 0.88

Synthesis of novel peptide nucleic acid-peptide chimera for non-invasive imaging of cancer. Nucleosides Nucleotides Nucleic Acids (2005) 0.87

Imaging spontaneous MMTVneu transgenic murine mammary tumors: targeting metabolic activity versus genetic products. J Nucl Med (2009) 0.87

VPAC1 receptors for imaging breast cancer: a feasibility study. J Nucl Med (2013) 0.87

The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster. Breast Cancer Res Treat (2014) 0.87

RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells. J Cell Biochem (2006) 0.86

Pyrrolo-C as a molecular probe for monitoring conformations of the tRNA 3' end. RNA (2008) 0.86

Label-free capture of breast cancer cells spiked in buffy coats using carbon nanotube antibody micro-arrays. Nanotechnology (2016) 0.84

Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles. Bioconjug Chem (2010) 0.84

Circulating human interleukin-8 as an indicator of cancer progression in a nude rat orthotopic human non-small cell lung carcinoma model. Cancer Epidemiol Biomarkers Prev (2008) 0.84

Fluorescent peptide-PNA chimeras for imaging monoamine oxidase A mRNA in neuronal cells. Bioconjug Chem (2012) 0.83

Targeting apoptosis for optical imaging of infection. Mol Imaging Biol (2012) 0.83

Transposon Tn7 protein TnsD binding to Escherichia coli attTn7 DNA and its eukaryotic orthologs. Biochemistry (2004) 0.82

Continuous solid-phase synthesis and disulfide cyclization of peptide-PNA-peptide chimeras. Org Lett (2002) 0.82

Synthesis and application of negatively charged PNA analogues. Nucleosides Nucleotides Nucleic Acids (2005) 0.82

Zebrafish tp53 knockdown extends the survival of irradiated zebrafish embryos more effectively than the p53 inhibitor pifithrin-alpha. Cancer Biol Ther (2007) 0.81

Physiologically based pharmacokinetics of molecular imaging nanoparticles for mRNA detection determined in tumor-bearing mice. Oligonucleotides (2010) 0.81

Nanotechnology for sensing, imaging, and treating cancer. Surg Oncol Clin N Am (2007) 0.81

Design of (Gd-DO3A)n-polydiamidopropanoyl-peptide nucleic acid-D(Cys-Ser-Lys-Cys) magnetic resonance contrast agents. Biopolymers (2008) 0.80

Effects of hypoxanthine substitution in peptide nucleic acids targeting KRAS2 oncogenic mRNA molecules: theory and experiment. J Phys Chem B (2013) 0.80

Imaging oncogene expression. Eur J Radiol (2009) 0.80

Imaging oncogene expression. Ann N Y Acad Sci (2003) 0.80

Natural human gene correction by small extracellular genomic DNA fragments. Cell Cycle (2007) 0.78

Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA. Nucl Med Biol (2013) 0.78

Stereospecific Grignard-Activated Solid Phase Synthesis of DNA Methylphosphonate Dimers. J Org Chem (1996) 0.78

STa peptide analogs for probing guanylyl cyclase C. Biopolymers (2008) 0.78

Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos. Int J Radiat Oncol Biol Phys (2006) 0.78

Uptake, efflux, and mass transfer coefficient of fluorescent PAMAM dendrimers into pancreatic cancer cells. Biochim Biophys Acta (2012) 0.78

Bactericidal activity of extended 9-glycyl-amido-minocyclines. Bioorg Med Chem Lett (2007) 0.77

Fluorescence detection of KRAS2 mRNA hybridization in lung cancer cells with PNA-peptides containing an internal thiazole orange. Bioconjug Chem (2014) 0.77

Synthesis of novel polydiamidopropanoate dendrimer PNA-peptide chimeras for non-invasive magnetic resonance imaging of cancer. Nucleosides Nucleotides Nucleic Acids (2005) 0.77

Static micro-array isolation, dynamic time series classification, capture and enumeration of spiked breast cancer cells in blood: the nanotube-CTC chip. Nanotechnology (2016) 0.76

Evaluation of glucocorticoid sensitivity in 697 pre-B acute lymphoblastic leukemia cells after overexpression or silencing of MAP kinase phosphatase-1. J Cancer Res Clin Oncol (2005) 0.76

Correspondence re: S. Heckl et al., Intracellular visualization of prostate cancer using magnetic resonance imaging. Cancer Res 2003;63:4766-72. Cancer Res (2004) 0.75

Consistent surgeon evaluations of three-dimensional rendering of PET/CT scans of the abdomen of a patient with a ductal pancreatic mass. PLoS One (2013) 0.75

Site-specific cleavage of RNA and DNA by complementary DNA--bleomycin A5 conjugates. Bioconjug Chem (2003) 0.75